EYESENS: Implantable System for Continuous and Direct Intraocular Pressure Measurements to Improve the Medical Management of Glaucoma

• Research unit: INNOSUISSE
• Project number: 14309.1;5 PFLS-LS

Short description (English)

EYESENS: Implantable System for Continuous and Direct Intraocular Pressure Measurements to Improve the Medical Management of Glaucoma

Short description (French)

EYESENS: Implantable System for Continuous and Direct Intraocular Pressure Measurements to Improve the Medical Management of Glaucoma

Abstract (English)

The EYESENS project comprises the design and development of application specific integrated circuits (telemetry and sensor readout electronics) and MEMS pressure sensor for an implantable medical device which precisely, directly and continuously monitor the patient¿s intraocular pressure (IOP). After a first proof of concept using off-the-shelf components, we verified and positively confirmed the feasibility of the project. The size of the system, in particular the size of the ASIC, needs to be reduced by approximately 55%. This miniaturization is extremely important for the development of the whole system. The miniaturized device will in fact be compatible with standard micro-surgical procedures used during crystalline replacement in patients affected by cataracts.

Abstract (French)

The EYESENS project comprises the design and development of application specific integrated circuits (telemetry and sensor readout electronics) and MEMS pressure sensor for an implantable medical device which precisely, directly and continuously monitor the patient¿s intraocular pressure (IOP). After a first proof of concept using off-the-shelf components, we verified and positively confirmed the feasibility of the project. The size of the system, in particular the size of the ASIC, needs to be reduced by approximately 55%. This miniaturization is extremely important for the development of the whole system. The miniaturized device will in fact be compatible with standard micro-surgical procedures used during crystalline replacement in patients affected by cataracts.